RVMD
Revolution Medicines, Inc.
NASDAQ · USHealthcareBiotechnology
$180.39-3.10%
Price as of Jul 20, 2026
RVMD capital
Revolution Medicines, Inc. capital & dividend
Leverage, liquidity, debt coverage and shareholder-distribution metrics.
Leverage
- Debt / equity
- 0.29x
- Net debt / equity
- -0.00x
- Debt / assets
- 0.19x
- Debt / EBITDA
- -0.33x
- Net debt / EBITDA
- 0.00x
Liquidity & coverage
- Current ratio
- 6.80x
- Quick ratio
- 6.80x
- Cash ratio
- 6.59x
- Interest coverage
- -39.00x
- EBITDA / interest
- -37.08x
- Working capital
- $1.7B
Cash & dividend
- FCF / debt
- -2.45x
- Cash flow / debt
- -2.42x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.